These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 839597

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R, Mittelman A, Kaufman J, Murphy GP.
    N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F, Kisbenedek L.
    Int Urol Nephrol; 1975 Nov; 7(2):135-40. PubMed ID: 1102475
    [Abstract] [Full Text] [Related]

  • 25. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A, Norlén BJ, Högberg B, Rajalakshmi M, Cekan SZ, Diczfalusy E.
    Scand J Urol Nephrol; 1981 Nov; 15(1):37-44. PubMed ID: 6787701
    [Abstract] [Full Text] [Related]

  • 26. [Estracyt treatment in prostatic neoplasms].
    Sander S.
    Tidsskr Nor Laegeforen; 1976 Jan 10; 96(1):27-8. PubMed ID: 1257949
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G, Högberg B, Nilsson T.
    Scand J Urol Nephrol; 1977 Jan 10; 11(3):231-8. PubMed ID: 339329
    [Abstract] [Full Text] [Related]

  • 28. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC.
    Wis Med J; 1976 Sep 10; 75(9):S89-90. PubMed ID: 969557
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of advanced carcinoma of the prostate with Estracyt.
    Nagel R, Kölln CP.
    Prog Clin Biol Res; 1976 Sep 10; 6():267-84. PubMed ID: 1023214
    [No Abstract] [Full Text] [Related]

  • 31. [Personal experience with treatment of advanced prostatic carcinoma using Estracyt].
    Morávek P.
    Rozhl Chir; 1987 Nov 10; 66(11):749-52. PubMed ID: 3424018
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
    Johnson DE, Scott WW, Gibbons RP, Prout GR, Schmidt JD, Chu TM, Gaeta J, Saroff J, Murphy GP.
    Cancer Treat Rep; 1977 Nov 10; 61(2):317-23. PubMed ID: 141326
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Chemotherapy of advanced prostate cancer].
    Murphy GP.
    Vopr Onkol; 1977 Nov 10; 23(12):26-38. PubMed ID: 146305
    [No Abstract] [Full Text] [Related]

  • 38. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH, Suciu S, Robinson MR, Richards B, Bastable JR, Glashan RW, Bouffioux C, Lardennois B, Williams RE, de Pauw M.
    J Urol; 1986 Sep 10; 136(3):619-23. PubMed ID: 3525866
    [Abstract] [Full Text] [Related]

  • 39. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W, Wegner G.
    Scand J Urol Nephrol Suppl; 1980 Sep 10; 55():147-9. PubMed ID: 6938018
    [Abstract] [Full Text] [Related]

  • 40. Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900.
    Schmidt JD.
    Prostate; 1984 Sep 10; 5(4):387-99. PubMed ID: 6377283
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.